Reportedly, on an appeal filed by Cipla pertaining to COPD drug INDAFLO, the Delhi High court division bench maintained the interim injunction imposed by a single judge […]
Reportedly, on an appeal filed by Cipla pertaining to COPD drug INDAFLO, the Delhi High court division bench maintained the interim injunction imposed by a single judge […]
An enforceable Patent being the key to effective Commercialization/Out-Licensing of any technology needs to be drafted well. No matter how good a technology is, if the description […]
India, though in a phase of rapid economic development, still has the bane of poverty. In this country, around 22% of the population is below the Poverty […]
An attempt to analyze the case study related to section 3 (k) of Patent Act, 1970 as follows: Accenture Global Service GMBH (Appellants) Vs Assistant Controller of […]
This article focuses on the revocation proceedings which is one of the mechanisms available for annulations of Patents in India. 1. What is the revocation of a […]
In Teva Parenteral Medicines, Inc.; APP Pharmaceuticals LLC; Pliva Hrvatska D.O.O.; Teva Pharmaceuticals USA, Inc.; and Barr Laboratories, Inc. (hereinafter referred to be as Defendants/Appellants/Teva) Vs. Eli […]
With effect from May 16, 2016 (effective date for Patent (amendment) rules, 2016), the provision of the expedited examination was introduced in the Patent system of India. […]
Shireen Shukla, a legal intern at Khurana & Khurana, probes the recent International IP Index report, released by the U.S. Chamber of Commerce, where India stood at […]
With business models over the world turning more idea-driven, Intellectual Property Rights (IPRs) are now one of the most valuable assets for any economy. With a significant […]
The once-powerful mobile phone companies BlackBerry and Nokia are in the headlines again, not for their new technological developments but because of their legal battle. The Valentine’s […]